Difference between revisions of "PL Lodz Watala C"
From Bioblast
Marte Verena (talk | contribs) |
|||
| Line 8: | Line 8: | ||
|country=Poland | |country=Poland | ||
|weblink=[http://www.flawopiryna.pl/ flawopiryna] | |weblink=[http://www.flawopiryna.pl/ flawopiryna] | ||
|Contact=Watala | |Contact=Watala Cezary | ||
|MiPNetLab=Labieniec-Watala | |MiPNetLab=Labieniec-Watala Magdalena, Dudzinska Dominika, Novak Joanna, Siewiera Karolina | ||
|Status=O2k 2010- | |Status=O2k 2010- | ||
|info=[[Bioblast 2012]], [http://www.oroboros.at/index.php?id=ioc72 IOC72], [[IOC61]], [http://www.oroboros.at/?IOC55-56 IOC55-56] | |info=[[Bioblast 2012]], [http://www.oroboros.at/index.php?id=ioc72 IOC72], [[IOC61]], [http://www.oroboros.at/?IOC55-56 IOC55-56] | ||
Revision as of 14:04, 27 August 2014
Areas of interest
- Mitochondrial respiratory capacity under normal and pathophysiological conditions (diabetes mellitus, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
- Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
- Targeting of biochemical and molecular burden of diabetes
Gentle Science
- Link to Gentle Science.
Feedback
- Everything what concerns OROBOROS company (oxygraphs, company staff, workshops, conferences, scientific discussions, the quality of information, etc.) works at the highest level !!!!!!! BRAVO for you :) - Magdalena Labieniec-Watala (2013)
- It is great that you develop the Oxygraph-2k in so wonderful directions.. excellent :))). - Magdalena Labieniec-Watala (2011)
